ReviewJournal of gynecologic oncology2019
Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri.
Abstract readReview
In one paragraph
Review in Journal of gynecologic oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Incidence, characteristics, and exploratory analysis of factors associated with pelvic osteitis/osteoradionecrosis after radiotherapy for cervical cancer: a single-center retrospective cohort study with an unmatched case-control analysis.Translational cancer research · 2026Article
- Microbiota-Derived Corisin Is Elevated in Early Cervical Neoplasia and Drives Pathogenic Cellular Programs.Cells · 2026Article
- Differentially Expressed Genes Identify FIGO Stage II Cervical Cancer Patients with a Higher Risk of Relapse in a Small Cohort.Journal of personalized medicine · 2025Article
- Surgical Advancements, Immunotherapy, Targeted and Conventional Therapies, Biopsy, Colposcopy, and Pap Smear Integration in the Management of Cervical Cancer.Current medicinal chemistry · 2025Review
- The impact of boost radiation therapy after hysterectomy on cervical cancer patients with close or positive resection margins.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Article
- The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer.Medicina (Kaunas, Lithuania) · 2023Observational
- Reduced field-of-view DWI‑derived clinical-radiomics model for the prediction of stage in cervical cancer.Insights into imaging · 2023Article
- ISG15 is associated with cervical cancer development.Oncology letters · 2022Article
- Influence of New FIGO 2018 Staging on Treatment Outcomes in Early-Stage Cervical Cancer: A Single-Center Study.South Asian journal of cancer · 2022Article
- Molecular Patho-mechanisms of cervical cancer (MMP1).Annals of medicine and surgery (2012) · 2022Review
- Article
- Post treatment imaging in patients with local advanced cervical carcinoma.Frontiers in oncology · 2022Review
- Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.European radiology · 2021Article
- A review and case report of enigmatic superficial endometrial spread of cancer of the uterine cervix: Need for vigilance in the primary care setting.Journal of family medicine and primary care · 2021Article
- [Uterine Cervical Cancer: Emphasis on Revised FIGO Staging 2018 and MRI].Taehan Yongsang Uihakhoe chi · 2021Review
- Implications of the revised cervical cancer FIGO staging system.The Indian journal of medical research · 2021Review
- Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer.Current oncology (Toronto, Ont.) · 2021Article
- Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study.Journal of oncology · 2021Review
- A 70-Gene Signature for Predicting Treatment Outcome in Advanced-Stage Cervical Cancer.Molecular therapy oncolytics · 2020Article
- Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D.The Journal of international medical research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Jonathan S BerekStanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.ORCID https://orcid.org/0000-0002-8734-1961
Koji MatsuoDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-6232-8701
Brendan H GrubbsDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-1963-4922
David K GaffneyDepartment of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-5752-1611
Susanna I LeeDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0003-2195-2943
Aoife KilcoyneDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-9278-170X
Gi Jeong CheonDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1360-5186
Chong Woo YooDepartment of Pathology, National Cancer Center, Goyang, Korea.ORCID https://orcid.org/0000-0002-5221-4516
Lu LiCollege of Basic Medical Sciences, Zhejiang Chinese Medical University (ZCMU), Hangzhou, China.ORCID https://orcid.org/0000-0002-9746-050X
Yifeng ShaoDepartment of Obstetrics and Gynecology, 1st affiliated hospital, Zhejiang Chinese Medical University, Hangzhou, China.ORCID https://orcid.org/0000-0002-7981-7042
Tianhui ChenGroup of Molecular Epidemiology & Cancer Precision Prevention (GMECPP), Zhejiang Academy of Medical Sciences (ZJAMS), Hangzhou, China.ORCID https://orcid.org/0000-0003-4677-0361
Miseon KimDepartment of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5118-9275
Mikio MikamiDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan. mmikami@is.icc.u-tokai.ac.jp.ORCID https://orcid.org/0000-0002-7496-3518
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diagnostic ImagingFemaleHumansLymph NodesNeoplasm StagingUterine Cervical Neoplasms
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.